Moderna Inc. (MRNA) shares rose 9.2% on Thursday, making the biotechnology company one of the top performers in the S&P 500. Investors responded positively to new pipeline updates, encouraging influenza vaccine data, and favorable analyst commentary.The stock extended its recent rally after climbing to a new annual high on Wednesday.…
The Dow Jones Industrial Average climbed to a record high on Thursday after a weaker-than-expected US jobs report reduced…
Samsung Electronics and SK Hynix stocks rebounded on Friday, as bargain hunters returned to South Korea’s biggest chipmakers after…
Asian markets found a steadier footing on Friday as investors took a softer US jobs report as a reason…
Chipmaker Nvidia has introduced a new revenue-sharing programme designed to support fast-growing artificial intelligence startups by providing access to…
Cathie Wood’s ARK Innovation ETF has bought back into SoFi Technologies (NASDAQ: SOFI) just as the beaten-down fintech stock is…
Hims & Hers Health shares (HIMS) surged 9% on Wednesday after Canaccord Genuity raised its price target on the…
Microsoft MSFT shares rose 4% on Wednesday after consumer health company Haleon announced a new five-year agreement to expand…